Literature DB >> 2302674

Estimation of validity of mass screening program for gastric cancer in Osaka, Japan.

R Murakami1, H Tsukuma, T Ubukata, K Nakanishi, I Fujimoto, T Kawashima, H Yamazaki, A Oshima.   

Abstract

To assess the validity of mass screening tests for gastric cancer conducted with three types of radiographic techniques, i.e., photofluorography by a mirror camera, photofluorography by an image intensifier, and direct radiography, 105,122 persons who underwent a total of 272,667 screening tests during 1970 through 1982 were followed through December 31, 1983 by means of a record linkage to the Osaka Cancer Registry, Osaka, Japan. The results of 1 year's follow-up from screening were defined as the gold standard and test performance values were calculated. Sensitivity of screening with photofluorography by a mirror camera, photofluorography by an image intensifier, and direct radiography was 90%, 89%, and 91%, and specificity was 86%, 92%, and 91%, respectively. The receiver operating characteristics curve for screening with photofluorography by an image intensifier resembled that for direct radiography and these two curves were located somewhat to the left of the curve for screening with photofluorography by a mirror camera. The authors conclude that the validity of screening with photofluorography by an image intensifier is almost equivalent to that of screening with direct radiography and both are superior to that of screening with photofluorography by a mirror camera.

Entities:  

Mesh:

Year:  1990        PMID: 2302674     DOI: 10.1002/1097-0142(19900301)65:5<1255::aid-cncr2820650536>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Gastric cancer screening in Korea: report on the national cancer screening program in 2008.

Authors:  Kyung Sook Lee; Dong Kwan Oh; Mi Ah Han; Hoo-Yeon Lee; Jae Kwan Jun; Kui Son Choi; Eun-Cheol Park
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

2.  Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.

Authors:  Shigeto Mizuno; Masao Kobayashi; Shohken Tomita; Ikuya Miki; Atsuhiro Masuda; Mitsuko Onoyama; Yasuki Habu; Hideto Inokuchi; Yoshiyuki Watanabe
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

3.  Improved detection of gastric cancer during screening by additional radiographs as judged necessary by the radiographer.

Authors:  Hidetoshi Yatake; Yoshihiro Takeda; Toshizo Katsuda; Chikazumi Kuroda; Hideo Yamazaki; Rumi Gotanda; Tatsuhiro Gotanda; Koichi Yabunaka; Masaaki Nagamatsu
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

Review 4.  Current practice for gastric cancer treatment in Ukraine.

Authors:  Andrii Sydiuk
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-16

5.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

6.  The correlation between gastric cancer screening method and the clinicopathologic features of gastric cancer.

Authors:  Ji-Youn Han; Hyehyun Son; Won Chul Lee; Byung Gil Choi
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

7.  Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.

Authors:  Helgi H Helgason; Judith Y M N Engwegen; Mark Zapatka; Annemieke Cats; Henk Boot; Jos H Beijnen; Jan H M Schellens
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

Review 8.  The epidemiology of gastric cancer.

Authors:  David M Roder
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

9.  Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity.

Authors:  Sailaja Kamaraju; Jeffrey Drope; Rengaswamy Sankaranarayanan; Surendra Shastri
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

10.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.